Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spero Therapeutics (SPRO) Minority Interest (2016 - 2019)

Historic Minority Interest for Spero Therapeutics (SPRO) over the last 4 years, with Q3 2019 value amounting to $355000.0.

  • Spero Therapeutics' Minority Interest changed 0.0% to $355000.0 in Q3 2019 from the same period last year, while for Sep 2019 it was $355000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $355000.0 for FY2018, which is 0.0% changed from last year.
  • Spero Therapeutics' Minority Interest amounted to $355000.0 in Q3 2019, which was down 0.0% from $355000.0 recorded in Q2 2019.
  • In the past 5 years, Spero Therapeutics' Minority Interest registered a high of $361000.0 during Q3 2017, and its lowest value of -$3.8 million during Q4 2016.
  • Over the past 4 years, Spero Therapeutics' median Minority Interest value was $355000.0 (recorded in 2017), while the average stood at -$60700.0.
  • As far as peak fluctuations go, Spero Therapeutics' Minority Interest skyrocketed by 10932.25% in 2017, and later tumbled by 166.2% in 2018.
  • Over the past 4 years, Spero Therapeutics' Minority Interest (Quarter) stood at -$3.8 million in 2016, then skyrocketed by 109.32% to $355000.0 in 2017, then changed by 0.0% to $355000.0 in 2018, then changed by 0.0% to $355000.0 in 2019.
  • Its last three reported values are $355000.0 in Q3 2019, $355000.0 for Q2 2019, and $355000.0 during Q1 2019.